Journal article icon

Journal article

Proportion attributable to contextual effects in general medicine: a meta-epidemiological study based on Cochrane reviews

Abstract:
PurposeTo quantify the proportion of the overall clinical improvement produced by intra-articular mesenchymal stem cell (MSC) injections for knee osteoarthritis (KOA) that is attributable to contextual (placebo-related) effects.MethodsThis PRISMA-compliant systematic review and meta-analysis (PROSPERO CRD420251026818) searched five databases (CENTRAL, Embase, MEDLINE, Web of Science and Scopus) to 24 March 2025. Randomized controlled trials enrolling adults with KOA that compared MSC injections with inert placebo were included. Primary outcome was change in pain intensity (VAS or WOMAC-pain); physical function was analysed secondarily. Two reviewers independently extracted data and assessed risk of bias. The proportion of the treatment effect attributable to contextual factors (PCE) was calculated as described by Tsutsumi et al. Pain and function outcomes at 6 and 12 months were pooled with inverse-variance random-effects meta-analysis, and evidence certainty was appraised using GRADE.ResultsEight RCTs (467 patients) met the inclusion criteria. At 6 months, contextual factors accounted for approximately 63% of pain reduction and 61% of functional improvement, with low heterogeneity (I2 ≤ 8%). At 12 months, contextual factors explained ~50% of pain relief and ~66% of functional gains, again with very low heterogeneity (I2 = 0%). Certainty of evidence was rated low for both time-points (GRADE).ConclusionBased on low-certainty evidence, this meta-analysis suggests that in knee osteoarthritis the majority of symptomatic improvement following intra-articular MSC injections is attributable to contextual (placebo) effects, whereas the MSCs themselves confer only a modest incremental benefit.Systematic review registrationCRD4-2025-1636181, https://www.crd.york.ac.uk/PROSPERO/view/CRD420251026818
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1136/bmjebm-2021-111861

Authors

More by this author
Role:
Author
ORCID:
0000-0002-9160-0241
More by this author
Role:
Author
ORCID:
0000-0002-7214-5589
More by this author
Role:
Author
ORCID:
0000-0003-3926-8867
More by this author
Role:
Author
ORCID:
0000-0003-0109-7425
More by this author
Role:
Author
ORCID:
0000-0003-3854-4081


Publisher:
BMJ Publishing Group
Journal:
BMJ Evidence-Based Medicine More from this journal
Volume:
28
Issue:
1
Pages:
40-47
Publication date:
2022-07-19
Acceptance date:
2022-06-24
DOI:
EISSN:
2515-4478
ISSN:
2515-446X


Language:
English
Keywords:
Pubs id:
1270356
Local pid:
pubs:1270356
Source identifiers:
W4285794253
Deposit date:
2026-04-27
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP